Shares of Liquidia (LQDA) are higher in Wednesday morning trading after the United States Court of Appeals for the Federal Circuit affirmed a patent board decision related to the company’s patent fight with United Therapeutics (UTHR). “We have considered UTC’s remaining arguments and find them unpersuasive. For the reasons provided above, we affirm the Board’s unpatentability determination,” the court stated in a ruling posted to its website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LQDA:
- Liquidia director Manning buys 279,330 common shares
- Liquidia prices 3.49M shares at $7.16 in underwritten public offering
- Liquidia Announces Pricing of Public Offering of Common Stock
- Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Liquidia reports Q3 EPS (24c), consensus (21c)
